PSYCF (Psyched Wellness) Research & Development: $1.75 Mil (TTM As of Feb. 2026)


What is Psyched Wellness Research & Development?

Psyched Wellness PSYCF Research & Development is $1.75 Mil as of Feb. 2026. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Psyched Wellness's Research & Development for the three months ended in Feb. 2026 was $0.47 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Feb. 2026 was $1.75 Mil.

Psyched Wellness  (OTCPK:PSYCF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Psyched Wellness Research & Development Related Terms

Psyched Wellness Research & Development Historical Data

* Premium members only.

The historical data trend for Psyched Wellness's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Psyched Wellness Research & Development Chart

Psyched Wellness Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.43 0.71 0.06 1.18 1.65

Psyched Wellness Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.46 0.35 0.46 0.47

Psyched Wellness Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $1.75 Mil mean?
Psyched Wellness (PSYCF) has a Research & Development of $1.75 Mil as of Feb. 2026. Research and development expense is the total cost for research and development activities. View historical data on Psyched Wellness and its competitors.
Is Psyched Wellness' Research & Development too high?
Psyched Wellness' current Research & Development is $1.75 Mil.
How does Psyched Wellness' Research & Development compare to KHC and GIS?
Psyched Wellness' Research & Development of $1.75 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Consumer Packaged Goods company?
A good Research & Development depends on the Consumer Packaged Goods industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Psyched Wellness and its competitors. Psyched Wellness's current Research & Development is $1.75 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Psyched Wellness stock overvalued right now?
Based on GuruFocus' analysis, Psyched Wellness (PSYCF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.05, compared to a current price of $0.01 — trading 84.4% below its estimated fair value. The current Research & Development is $1.75 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Psyched Wellness (PSYCF), the current Research & Development is $1.75 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Psyched Wellness Business Description

Other Exchanges 5U9:GermanyPSYC:Canada
Address 36 Toronto Street, Suite 701, Toronto, ON, CAN, M5C 2C5
Psyched Wellness Ltd is a Canada-based health supplements company, which is engaged in the distribution of mushroom-derived products and associated consumer packaged goods. The Company is producing and developing a line of Amanita Muscaria-derived water-based extracts, teas and capsules designed to help with three health objectives, such as promote stress relief, relaxation, and assist with restful sleeping. The Company's subsidiaries include Psyched Wellness Corp., and AME Wellness Inc.